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Background: Hepatitis B virus (HBV) infection is highly endemic in many Asian countries.
Objectives: We examined whether prior contraceptive methods and sexual behavioral 
factors impact maternal HBV carriage in an obstetric population.
Patients and Methods: For this study, pregnant women were considered to be representa-
tive of the sexually active and fertile female population. Contraceptive methods used 
prior to the index pregnancy were examined in 1283 pregnant Chinese women attending 
an antenatal clinic using a self-administered questionnaire, and correlated with the ma-
ternal HBV status determined using routine antenatal screening.
Results: In our study, 111 (8.7%) women were infected with HBV and there was no diﬀerence 
in the incidence of male condom usage between HBV-positive (88.3%) and HBV-negative 
(83.5%) women. No contraceptive method was associated with a reduced incidence of 
maternal HBV carriage, except for coitus interruptus. In multivariate analysis, only mul-
tiparity (adjusted odds ratio [aOR], 1.62) and more than 1 sexual partner (aOR, 1.57) were 
independent factors associated with maternal HBV carriage.
Conclusions: Contraceptive use played only a minimal role in preventing sexual transmis-
sion of HBV infection within the sexually active female population in an endemic area.
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1. Background
Hepatitis B infection is an infectious disease with over 
350 million chronic carriers worldwide (1). It is highly 
endemic in many Asian countries such as Hong Kong. 
Hepatitis B virus (HBV) infection can be acquired dur-
ing embryonic development through vertical and peri-
natal transmission from a carrier mother, as well as by 
horizontal transmission through contact with blood 
and other body ﬂuids. HBV infection can also be sexu-
ally transmitted in adults (2-4), particularly in high-risk 
groups such as homosexual males (5, 6). Among ho-
mosexual males, HBV is transmitted 8.6-fold more eﬃ-
ciently than HIV infection (6). Furthermore, unprotected 
sexual exposure is an important mode of transmission 
in the Chinese population (7). Controlling HBV infection 
is dependent on interrupting its transmission among 
individuals, and therefore failure to interrupt its trans-
mission during sexual intercourse may inﬂuence the 
prevalence of HBV infection. Hong Kong is endemic in 
chronic HBV infection, with an overall prevalence of ap-
proximately 10% in the obstetric population (8); thus, an-830
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tenatal screening for hepatitis B surface antigen (HBsAg) 
status is performed routinely. A previous study showed 
that among the standard contraceptive methods avail-
able, the male condom is the most popularly used meth-
od (9). Since condom usage has the additional eﬀect of 
protecting against sexually transmitted diseases (10), the 
prevalence of HBV infection among the obstetric popula-
tion may be inﬂuenced by the previous use of condoms 
before the index pregnancy. 
2. Objectives
Since little information is available regarding the re-
lationship between the use of contraceptive methods 
before pregnancy and HBV carriage diagnosed during 
the antenatal period in the obstetric population of an 
endemic region, we conducted a cross-sectional study 
on unselected pregnant women attending an antenatal 
clinic to elucidate the relationship between maternal 
HBV carriage, and the use of contraceptive methods as 
well as demographic, obstetric, and sexual behavioral 
factors.
3. Patients and Methods
3.1. Patients and Study Procedures
A prospective, cross-sectional questionnaire-based sur-
vey to investigate health issues in the obstetric popula-
tion was conducted in a university obstetric unit in Hong 
Kong over a 2-month period in 2008. Ethical approval was 
obtained from the hospital Institutional Review Board. 
Brieﬂy, a total of 2000 questionnaires were distributed 
to consecutive Chinese women attending the antenatal 
clinic who were invited to participate in the study. Con-
senting women were asked to complete the question-
naire by themselves without advice or interference dur-
ing their waiting time and to return the questionnaire to 
the medical staﬀ at the time of antenatal examination. 
We limited the study to include Chinese women to elimi-
nate the confounding eﬀects of varying ethnicities and 
cultural backgrounds. Details regarding recruitment 
were described previously (11), and ﬁndings from diﬀer-
ent parts of the study have been reported previously 
(11-13). Data regarding contraception and maternal hepa-
titis B status was the focus of this portion of the study. 
Conﬁning the study to include Chinese women mini-
mized the potential impact of cultural diﬀerences such 
as the attitude towards sexual behavior and the choice 
of contraceptive methods in the local female population 
of reproductive age. Questionnaires with incomplete 
answers concerning the contraception method used 
were excluded from the data. The survey instrument 
contained questions regarding the number of sexual 
partners of each respondent and the last contraceptive 
methods used before the index pregnancy. More than 1 
choice could be selected for previously used contracep-
tive methods. The questionnaire also included informa-
tion regarding sociodemographic factors and obstetric 
characteristics. Questionnaires with incomplete data on 
contraceptive methods used were excluded from ﬁnal 
analysis. Hormonal injections, oral contraceptive pills 
(OCP), emergency contraception, and hormonal patches 
and implants were categorized as hormonal contracep-
tive methods, while the male condom, coitus interrup-
tus, safety period, and spermicides were categorized as 
barrier contraceptive methods. Intrauterine contracep-
tive devices (IUCD) were analyzed as a separate group.
In Hong Kong, antenatal screening of maternal HBsAg 
status is routinely used to identify high-risk pregnancies 
for combined active-passive immunization to newborn 
infants who would otherwise receive only the hepatitis B 
vaccine at birth. Testing for hepatitis B surface antibody 
and hepatitis B e-antigen is not performed for those who 
tested negative for HBsAg. Therefore, the identiﬁcation 
of maternal HBV infection in this study is dependent 
on a positive HBsAg status at routine antenatal screen-
ing, which is performed either at the Maternal and Child 
Health Centers or at the booking hospital. For subjects 
in this study, the results of the HBsAg screening were 
retrieved from an antenatal database. The relationship 
between HBV carriage and the use of each contraceptive 
method, as well as the use of hormonal, barrier, and IUCD 
methods, were analyzed.
3.2. Statistical Analysis
Statistical analysis was performed using the Statistical 
Package for Social Science (SPSS) version 17.0 (SPSS, Chi-
cago, IL, USA). The distribution of continuous data was 
tested for normality. Continuous variables were com-
pared using the t-test or Mann-Whitney U-test as appro-
priate. Categorical variables were compared using the 
chi-square test or Fisher exact test. The level of statistical 
signiﬁcance was set at P < 0.05 (2-sided). Variables found 
to be signiﬁcant in univariate analysis and all contracep-
tion methods were included in multivariate analysis. Lo-
gistic regression analysis was performed to delineate fac-
tors associated with hepatitis B status. Odds ratios (OR), 
adjusted odds ratios (aOR), and 95% conﬁdence intervals 
(CI) were estimated. 
4. Results
A total of 1697 questionnaires were collected from the 
recruited women during the study period, yielding a re-
sponse rate of 84% for the entire study. Among these, 315 
women had not used contraception and 52 women did 
not answer this question. Therefore, 1330 valid question-
naires were used for this study. Within this group, 47 did 
not proceed with further antenatal care in our hospital 
after attending the ﬁrst-trimester combined screening 
program for Down’s syndrome. Therefore, HBsAg status 
was determined only in 1283 women, of whom 111 (8.7%) 
were positive and 1172 (91.3%) were negative. There were 
no signiﬁcant diﬀerences in HBsAg status between wom-
en who had used contraception (11.3%, P = 0.153) and those 
who did not respond to this question (5.1%, P = 0.768). In 
the study group, the mean age was 30.6 (standard devia-831
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tion [SD], 4.7) years. Most were born in Hong Kong (775, 
60.4%), were married or cohabiting (1189, 92.7%), and had 
resided in Hong Kong for at least 7 years (1001, 78.0%). 
There were 737 (57.4%) nulliparas and 545 (42.5%) multip-
aras. The 6 contraceptive methods used most frequently, 
in order of decreasing frequency, were the male condom 
(1077, 83.9%), safety period (301, 23.5%), coitus interruptus 
(274, 21.4%), OCP (147, 11.5%), IUCD (86, 6.7%), and hormonal 
injection (53, 4.1%).
The relationship between maternal HBsAg status, and 
contraceptive methods and obstetric and sexual behav-
ioral factors is shown in Table 1. Maternal HBV carriage 
was signiﬁcantly associated with a higher incidence of 
hormonal injection use (OR 2.26) and a lower incidence 
of coitus interruptus use (OR 0.51). In terms of obstetric 
and sexual behavioral factors, HBV carriage was associ-
ated with a higher incidence of multiparity (OR 1.54) and 
more than 1 sexual partner (OR 1.63). In the multivariate 
logistic regression analysis, which took into account all 
contraception methods, the use of hormonal injection 
(aOR 2.69, 95% CI 1.19–6.06, P = 0.017), multiparity (aOR, 
1.61; 95% CI, 1.08–2.41; P = 0.021), and more than 1 sexual 
partner (aOR, 1.57; 95% CI, 1.05–2.35; P = 0.028), were inde-
pendently associated with maternal HBV carriage, while 
use of coitus interruptus (aOR, 0.55; 95% CI, 0.30–1.01; P 
= 0.052) was just below the threshold for signiﬁcance 
in the association with reduced risk of HBV carriage. To 
eliminate the confounding eﬀects of parity and number 
of sexual partners in this study, each variable was strati-
ﬁed. For nulliparas, HBV carriage was associated with a 
higher incidence of using hormonal injection (OR, 5.35), 
IUCD (OR, 3.41) and a lower incidence of using coitus 
interruptus (OR, 0.41), while no signiﬁcant association 
with these factors was observed for multiparas (Table 2). 
Similarly, for women who had more than 1 sexual part-
ner, HBV carriage was associated with a higher incidence 
of using hormonal injection (OR, 3.54) and a lower in-
cidence of using coitus interruptus (OR, 0.37), while no 
such associations were observed for those with a single 
sexual partner (Table 3). 
Factors associated with the use of IUCD, hormonal, and 
barrier methods were examined. In our study group, 86 
(6.7%) women had used IUCD for contraception (7.2%  vs. 
6.7% for HBV-positive and HBV-negative respectively, P 
= 0.824), 184 (14.3%) had used hormonal methods (15.3% 
vs. 14.2%; P = 0.759), and 1144 (89.2%) had used barrier 
methods (92.8% vs. 88.8%; P = 0.198) as contraception. The 
frequency of these 3 methods used by women included 
in the study according to parity is shown in Table 4. For 
nulliparas, HBV carriage was associated with a higher 
incidence of using hormonal methods (OR, 2.18; 95% CI, 
1.14–4.16) and IUCD (OR, 3.41; 9    5% CI, 1.10–10.60); a trend 
towards a lower incidence of hormonal method use was 
observed in multiparas (OR, 0.33; 95% CI, 0.99–1.07). Mul-
tivariate logistic regressions were performed to explore 
factors associated with maternal HBV carriage while ad-
justing for these categories of contraceptive methods. 
Multiparity (aOR, 1.62; 95% CI, 1.09–2.42; P = 0.017) and 
more than 1 sexual partner (aOR, 1.57; 95% CI, 1.05–2.34; 
P = 0.028) were the only independent factors associated 
with maternal HBV carriage, while no categories of con-
traceptive methods were observed to have an independ-
ent association.
5. Discussion
A number of risk factors for HBV carriage have been 
identiﬁed in previous studies, including age, education 
level, history of jaundice, tattooing, presence of the HCV 
antibody, and a history of surgery (14-17). However, there 
is no consensus regarding factors for HBV carriage in 
the obstetric population. A previous study conducted 
                               HBsAg P value OR a (95% CI a)
Positive, No. (%) 
(n = 111)
Negative, No. (%)  
(n = 1172)
Contraceptive method
Safety period
Coitus interruptus
Male condom
Oral contraceptive pills
Hormonal injection
Hormonal patch
Emergency contraception
IUCD a
Implant
Spermicides
21 (18.9)
14 (12.6)
98 (88.3)
11 (9.9)
9 (8.1)
1 (0.9)
3 (2.7)
8 (7.2)
1 (0.9)
0 (0)
280 (23.9)
260 (22.2)
979 (83.5)
136 (11.6)
44 (3.8)
19 (1.6)
31 (2.6)
78 (6.7)
8 (0.7)
8 (0.7)
0.237
0.019
0.192
0.592
0.041
1.000
1.000
0.824
0.558
1.000
-
0.51 (0.28–0.90)
-
-
2.26 (1.07–4.77)
-
-
-
-
-
Demographic, obstetric, and sexual-related factors
Multiparity
Multi sexual partner, (n = 1181)
Used 2 or more contraception methods
Maternal age, mean ± SD
58 (52.3)
48 (48)
37 (33.3)
30.7 ± 4.7
487 (41.6)
391 (36.2)
430 (36.7)
30.5 ± 4.7
0.030
0.019
0.483
0.803
1.54 (1.04–2.27)
1.63 (1.08–2.46)
-
-
Table 1. Use of Contraceptive Methods, and Obstetric and Sexual Behavioral Factors Stratiﬁed by Maternal HBsAg Status (n = 1283)
a Abbreviation: CI, conﬁdence interval ;  IUCD, intrauterine contraceptive device ; OR, odds ratio832
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in Ghana among pregnant women showed that socio-
demographic and medical characteristics were not asso-
ciated with HBV carriage (18). However, there have been 
no reports regarding the relationship between the use of 
contraceptive methods or obstetric and sexual behavio-
ral factors, and HBV carriage in pregnant women. This is 
the ﬁrst study to examine this issue, particularly among 
a single ethnic group in a highly endemic area.
According to the World Health Organization deﬁni-
tion, Hong Kong is regarded as an endemic area for HBV 
infection. To control HBV infection in the population, a 
universal neonatal immunization program was intro-
duced in 1988 (19); the HBV vaccine has since been made 
available for all non-immunized individuals. However, 
the rate of maternal HBV infection has increased over the 
past 3 decades, from 6.6% in the 1970s (20) and 7.4% in the 
1980s (21), to 10.0% in the 1990s and the most recent dec-
ade (8, 19). We suspect that the failure to prevent trans-
mission during sexual intercourse, as well as inadequate 
knowledge and awareness regarding HBV transmission, 
is a major factor contributing to the persistent high rate 
of HBV infection (12). In the present study, we focused 
on contraceptive methods used previously by pregnant 
women, taking factors such as parity and number of 
sexual partners into account. Other sociodemographic 
and medical characteristics, such as occupation, educa-
tion level, and family income, were not included in the 
regression analysis, as they did not show a signiﬁcant 
association with HBV carriage in univariate analysis. In 
our study, the incidence of condom usage among HBsAg-
positive women (88.3%) did not signiﬁcantly diﬀer from 
that found among HBsAg-negative women (83.5%). On 
the other hand, maternal HBV carriage was associated 
with the use of hormonal injection (OR 2.26), and which 
was further increased for women with more than 1 sexual 
partner (OR 3.54) and for nulliparas (OR 5.35). In contrast, 
HBV carriage was associated with reduced usage of coi-
tus interruptus (OR 0.51), and it was further reduced in 
those with more than 1 sexual partner (OR 0.37) and nul-
liparas (OR 0.41). Both contraceptive methods remained 
signiﬁcant factors in the multivariate analysis after ad-
justment for parity and number of sexual partners.
We believe that, in a population endemic for HBV infec-
tion and with an extremely high usage of male condoms, 
the use of male condoms does not oﬀer a protective ef-
fect against HBV transmission. Only methods that in-
terrupt the transmission of seminal ﬂuid, such as coitus 
interruptus, are protective against HBV transmission, 
an eﬀect that is ampliﬁed in women with more than 1 
sexual partner and nulliparas. In contrast, as hormonal 
injection is an extremely eﬀective contraceptive method, 
women using this method were not at risk for becoming 
pregnant, and therefore tended to allow vaginal ejacu-
lation, increasing the risk of acquiring HBV infection, 
an eﬀect that was magniﬁed in women with more than 
1 sexual partner and in nulliparas. Although individual 
methods inﬂuenced the association with HBV carriage, 
various categories of contraceptive methods (IUCD, 833
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hormonal, and barrier methods) did not have a signiﬁ-
cant impact, and only multiparity and number of sexual 
partners remained independent factors for HBV car-
riage when these categories were analyzed together in 
the regression model. Our ﬁndings indicate that when 
HBV carriage is analyzed with respect to contraceptive 
methods, as well as with respect to social and sexual be-
havioral factors in the obstetric, sexually active popula-
tion, the use of various contraceptive methods played 
only a minimal role in facilitating or preventing the 
sexual transmission of HBV infection in an endemic area. 
There were some limitations to our study. Although our 
center is one of the largest obstetric units in our commu-
nity with 6000 deliveries per year, the sample studied 
may not have been representative of the entire obstetric 
population in Hong Kong. Some women are managed in 
the private sector as suggested by the subjects excluded 
from this study. Furthermore, although the women were 
asked to indicate previously used contraceptive meth-
ods, detailed information regarding which method was 
predominantly used when more than 1 method was used 
could not be obtained. Other risk factors for HBV car-
riage, such as history of jaundice, presence of the hepa-
titis C virus antibody, and a history of surgery, were not 
included on the questionnaire. A potential confounding 
factor in this study was that our women may not have 
truthfully disclosed or answered sensitive items about 
sexual behavioral history, particularly when accompa-
nied by their husbands or partners, thus resulting in un-
reliable responses. To exclude this confounding factor, 
we compared responses regarding the number of sexual 
partners from those attended the antenatal visit alone 
and those accompanied by others. There were no statis-
tically signiﬁcant diﬀerences between these 2 groups. 
Nevertheless, the ﬁndings of this study indicated that in 
highly endemic communities, no contraceptive method 
is associated with reduced incidence of maternal HBV 
carriage, except for coitus interruptus. The apparent pro-
tective eﬀect of this method on maternal HBV carriage, 
particularly in nulliparas and women with more than 1 
sexual partner, should be explored in further studies, as 
this method could be recommended to HBV-naïve wom-
en pending the establishment of HBV immunoprotec-
tion following vaccination.
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